3-(Methylamino)-2,3-dihydroinden-1-one | 81214-96-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: 3-(Methylamino)-2,3-dihydroinden-1-one
• CAS: 81214-96-2
• 化学式: C₁₀H₁₁NO
• 分子量: 161.203
• InChiKey: UZZPEANYUDVBGP-UHFFFAOYSA-N

物化性质

• 沸点：
  268.7±39.0 °C(Predicted)
• 密度：
  1.13±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-[(3,4-二氢-4-氧代-1-酞嗪基)甲基]-2-氟苯甲酸 、 3-(Methylamino)-2,3-dihydroinden-1-one 在 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下， 以 N,N-dimethyl-d₆-formamide 为溶剂， 反应 12.0h， 以68%的产率得到2-fluoro-N-methyl-N-(3-oxo-1,2-dihydroinden-1-yl)-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzamide
  参考文献：
  名称：

  Design, Synthesis, and Biological Evaluation of a Series of Benzo[de][1,7]naphthyridin-7(8H)-ones Bearing a Functionalized Longer Chain Appendage as Novel PARP1 Inhibitors

  摘要：

  A series of benzo[de][1,7]naphthyridin-7(8H)-ones possessing a functionalized long-chain appendage have been designed and evaluated as novel PARP1 inhibitors. The initial effort led to the first-generation PARP1 inhibitor 26 bearing a terminal phthalazin-1(2H)-one framework and showing remarkably high PARP1 inhibitory activity (0.31 nM) but only moderate potency in the cell. Further effort generated the second-generation lead 41, showing high potency against both the PARP1 enzyme and BRCA-deficient cells, especially for the BRCA1-deficient MDA-MB-436 cells (CC50 < 0.26 nM). Mechanistic studies revealed that the new PARP1 inhibitors significantly inhibited H2O2-triggered PARylation in SKOV3 cells, induced cellular accumulation of DNA double-strand breaks, and impaired cell-cycle progression in BRCA2-deficient cells. Significant potentiation on the cytotoxicity of Temozolomide was also observed. The unique structural character and exceptionally high potency of 41 made it stand out as a promising drug candidate worthy for further evaluation.

  DOI：

  10.1021/jm301825t
• 作为产物：
  描述：

  trifluoroacetylamino-4 indanone-1 在 四丁基溴化铵 、 potassium carbonate 、 barium(II) hydroxide 作用下， 以 甲醇 、 乙腈 为溶剂， 反应 36.0h， 生成 3-(Methylamino)-2,3-dihydroinden-1-one
  参考文献：
  名称：

  Design, Synthesis, and Biological Evaluation of a Series of Benzo[de][1,7]naphthyridin-7(8H)-ones Bearing a Functionalized Longer Chain Appendage as Novel PARP1 Inhibitors

  摘要：

  A series of benzo[de][1,7]naphthyridin-7(8H)-ones possessing a functionalized long-chain appendage have been designed and evaluated as novel PARP1 inhibitors. The initial effort led to the first-generation PARP1 inhibitor 26 bearing a terminal phthalazin-1(2H)-one framework and showing remarkably high PARP1 inhibitory activity (0.31 nM) but only moderate potency in the cell. Further effort generated the second-generation lead 41, showing high potency against both the PARP1 enzyme and BRCA-deficient cells, especially for the BRCA1-deficient MDA-MB-436 cells (CC50 < 0.26 nM). Mechanistic studies revealed that the new PARP1 inhibitors significantly inhibited H2O2-triggered PARylation in SKOV3 cells, induced cellular accumulation of DNA double-strand breaks, and impaired cell-cycle progression in BRCA2-deficient cells. Significant potentiation on the cytotoxicity of Temozolomide was also observed. The unique structural character and exceptionally high potency of 41 made it stand out as a promising drug candidate worthy for further evaluation.

  DOI：

  10.1021/jm301825t

文献信息

• Macrocyclic diaminopropanes as beta-secretase inhibitors
  申请人：Marcin R. Lawrence

  公开号：US20070037868A1

  公开（公告）日：2007-02-15

  There is provided a series of novel macrocyclic diaminopropanes of Formula (I) or a stereoisomer; or a pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , R 4 , R 5 , n, L, Z, and as defined herein, their pharmaceutical compositions and methods of use. These novel compounds inhibit the processing of amyloid precursor protein (APP) by β-secretase and, more specifically, inhibit the production of Aβ-peptide. The present disclosure is directed to compounds useful in the treatment of neurological disorders related to β-amyloid production, such as Alzheimer's disease and other conditions affected by anti-amyloid activity.

  提供了一系列新型的大环二胺丙烷化合物，其化学式为（I）或其立体异构体；或其药学上可接受的盐，其中R1、R2、R4、R5、n、L、Z等如本文定义，它们的药物组合物和使用方法。这些新型化合物抑制β-分泌酶对淀粉样前体蛋白（APP）的加工，更具体地说，抑制Aβ肽的产生。本公开涉及用于治疗与β-淀粉样蛋白产生相关的神经疾病的化合物，如阿尔茨海默病和其他受抗淀粉样活性影响的疾病。
• Fungicidal Carboxamides
  申请人：Bisaha John Joseph

  公开号：US20110269712A1

  公开（公告）日：2011-11-03

  This invention is directed to compounds of Formula (1) including all geometric and stereoisomers, N oxides, and agriculturally suitable salts thereof, agricultural compositions containing them and their use as fungicides, (1) provided that the compound of Formula 1 is other than 2-[1-[(2-chlorophenyl)acetyl]-4-piperidinyl]-N-methyl-N-[(1R)-1-phenylethyl]-4-thiazolecarboxamide and R 1 is other than 4-fluorophenyl; wherein R 1 , R 2 , A, G, Q, W 1 , W 2 , X and n are otherwise as defined in the disclosure, Also disclosed are compositions containing the a compound having a formula corresponding to Formula (1) where the provisos are both omitted; and methods for controlling plant diseases caused by fungal plant pathogens which involves applying an effective amount of a compound having a formula corresponding to Formula (1) where the provisos are both omitted.

  本发明涉及公式（1）的化合物，包括所有几何和立体异构体、N-氧化物和农业适用的盐，以及包含它们的农业组成物和它们作为杀真菌剂的用途，（1）前提是公式1的化合物不是2-[1-[(2-氯苯基)乙酰基]-4-哌啶基]-N-甲基-N-[(1R)-1-苯乙基]-4-噻唑羧酰胺，且R1不是4-氟苯基；其中R1、R2、A、G、Q、W1、W2、X和n的定义如本公开说明书中所定义，还披露了含有与省略前提条件的公式（1）相对应的化合物的组合物；以及用公式（1）相应的化合物控制由真菌植物病原体引起的植物病害的方法，其中涉及施用有效量的公式（1）相应的化合物，省略前提条件。
• FUNGICIDAL HETEROCYCLIC COMPOUNDS
  申请人：Pasteris Robert James

  公开号：US20110224258A1

  公开（公告）日：2011-09-15

  Disclosed are compounds of Formula 1, including all geometric and stereoisomers, tautomers, N-oxides, and salts thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , A, W, X, G, Z, J and n are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.

  本发明涉及一种公式1的化合物，包括其所有的几何和立体异构体、互变异构体、N-氧化物和盐，其中R1、R2、R3、R4、R5、A、W、X、G、Z、J和n的定义如本文所述。本发明还涉及包含公式1化合物的组合物，以及控制由真菌病原体引起的植物病害的方法，包括施用本发明中化合物或组合物的有效量。
• FUNGICIDAL CARBOXAMIDES
  申请人：E.I. DU PONT DE NEMOURS AND COMPANY

  公开号：EP1948649A2

  公开（公告）日：2008-07-30
• US7338974B2
  申请人：——

  公开号：US7338974B2

  公开（公告）日：2008-03-04